Drug search for leishmaniasis: a virtual screening approach by grid computing.

Area of Science:

• Parasitology
• Drug Discovery
• Computational Biology

Background:

• Leishmania parasites cause leishmaniasis, a disease affecting millions globally.
• Current treatments have severe side effects and face drug resistance.
• There is an urgent need for novel, safe, and affordable anti-leishmanial drugs.

Purpose of the Study:

• To discover new drug candidates for leishmaniasis using computational screening.
• To identify potent inhibitors targeting key Leishmania proteins.

Main Methods:

• Utilized IBM World Community Grid for large-scale virtual drug screening.
• Employed molecular dynamics simulations and the Relaxed Complex Scheme methodology.
• Screened 600,000 small molecules against Leishmania protein targets.

Main Results:

• Identified four Leishmania protein targets predicted to strongly bind small molecules.
• Dihydroorotate dehydrogenase (LmDHODH) showed the strongest predicted binding interactions.
• In vitro testing confirmed potent and selective inhibitors of Leishmania panamensis.

Conclusions:

• Computer-based drug discovery identified promising LmDHODH inhibitors.
• These compounds are suitable for further development as anti-leishmanial therapeutics.
• This approach addresses the critical need for new leishmaniasis treatments.